Castle Rock Hormone Health is targeting 100 to 250 new clinic openings in 2026, with a five-year goal of 1,500 locations. The Colorado-based company operates across five states (CO, GA, FL, PA, MI), has served more than 10,000 patients, and reports over $10 million in annual revenue at 25 percent year-over-year growth.
The March 2026 partnership with Franchise Sidekick, led by Co-Founder and Chief Growth Officer Tyler Altenhofen, brings a structured operator-matching process to the rollout, focused on quality over volume.
“This partnership is about finding franchise owners who share the same commitment to care that’s both data-driven and personal – not just adding locations for the sake of growth,” said Christopher Stolzman, Co-Founder and CEO.
The clinical model serves both men and women, covering low testosterone, perimenopause, and post-menopause, alongside medically guided weight loss, peptides, IV therapy, hair restoration, sexual wellness, and orthobiologics. Co-Founder and physician Dr. Lee Moorer developed the protocols around regular lab monitoring and individualized care.
“What we’re building is bigger than a brand – it’s a movement. For years, patients have been told to live with symptoms that were never truly addressed, and we’re proving there’s a better way,” Stolzman said.
The global HRT market is projected to grow from $27.56 billion in 2026 to $37.07 billion by 2031 (Mordor Intelligence). CRHH says it is the first franchise in the category to serve both men and women at a national concierge level.
